- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
164
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
164 companies
Charles River Laboratories International
Market Cap: US$7.3b
Charles River Laboratories International, Inc.
CRL
US$148.74
7D
-11.4%
1Y
-23.5%
Krka d. d
Market Cap: €6.1b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
KRKG
€198.00
7D
0%
1Y
47.2%
Repligen
Market Cap: US$6.3b
A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.
RGEN
US$111.43
7D
-4.4%
1Y
-31.9%
ALK-Abelló
Market Cap: DKK 39.4b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 178.10
7D
-4.7%
1Y
15.7%
Rhythm Pharmaceuticals
Market Cap: US$6.1b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$91.98
7D
1.9%
1Y
106.8%
Yuhan
Market Cap: ₩8.4t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩112,000.00
7D
-0.5%
1Y
28.3%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥42.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥90.13
7D
-8.7%
1Y
73.6%
SK Biopharmaceuticals
Market Cap: ₩7.8t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩98,800.00
7D
2.8%
1Y
0%
Ono Pharmaceutical
Market Cap: JP¥802.1b
Engages in production, purchase, and sale of pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥1,707.50
7D
4.1%
1Y
-19.6%
ABIVAX Société Anonyme
Market Cap: €4.6b
A clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.
ABVX
€60.40
7D
-1.3%
1Y
478.5%
Biocon
Market Cap: ₹458.2b
Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.
BIOCON
₹342.10
7D
-10.5%
1Y
1.3%
PharmaResearch
Market Cap: ₩6.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩680,000.00
7D
22.5%
1Y
289.5%
Xiamen Amoytop Biotech
Market Cap: CN¥34.6b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥86.40
7D
-3.5%
1Y
62.3%
RemeGen
Market Cap: HK$37.3b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$66.55
7D
12.5%
1Y
362.8%
Genscript Biotech
Market Cap: HK$37.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$17.24
7D
0.5%
1Y
33.6%
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥33.5b
Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.
688192
CN¥74.31
7D
1.6%
1Y
92.8%
Alkermes
Market Cap: US$4.4b
A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
ALKS
US$26.71
7D
0.3%
1Y
3.0%
InnoCare Pharma
Market Cap: HK$34.4b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$17.61
7D
-1.3%
1Y
281.2%
SCHOTT Pharma KGaA
Market Cap: €3.7b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.
1SXP
€24.40
7D
1.7%
1Y
-25.8%
China Medical System Holdings
Market Cap: HK$32.1b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.33
7D
2.6%
1Y
98.1%
Sotera Health
Market Cap: US$4.0b
Provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$13.97
7D
23.8%
1Y
-2.2%
LigaChem Biosciences
Market Cap: ₩5.4t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩149,500.00
7D
10.2%
1Y
58.4%
Simcere Pharmaceutical Group
Market Cap: HK$30.5b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$12.32
7D
-1.1%
1Y
120.0%
Yili Chuanning BiotechnologyLtd
Market Cap: CN¥27.2b
Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.
301301
CN¥12.37
7D
-2.2%
1Y
4.7%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥26.7b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥42.35
7D
2.8%
1Y
26.2%
Virbac
Market Cap: €2.8b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
VIRP
€331.50
7D
-1.5%
1Y
-2.9%
Prestige Consumer Healthcare
Market Cap: US$3.2b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$65.58
7D
-11.6%
1Y
0.5%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.7b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€53.75
7D
1.1%
1Y
-29.5%
Everest Medicines
Market Cap: HK$25.0b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$70.40
7D
4.6%
1Y
256.3%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س11.4b
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
4015
ر.س161.90
7D
0.5%
1Y
4.0%
Ligand Pharmaceuticals
Market Cap: US$2.9b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$150.06
7D
10.8%
1Y
50.7%
Bavarian Nordic
Market Cap: DKK 18.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 237.60
7D
-0.1%
1Y
23.0%
Hugel
Market Cap: ₩3.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩349,000.00
7D
7.2%
1Y
36.9%
Hanmi Pharm
Market Cap: ₩3.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩279,000.00
7D
0.9%
1Y
-2.4%
Crinetics Pharmaceuticals
Market Cap: US$2.5b
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
CRNX
US$26.85
7D
-4.9%
1Y
-45.8%
Guangdong Zhongsheng Pharmaceutical
Market Cap: CN¥17.7b
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
CN¥21.45
7D
3.2%
1Y
66.3%